Amyloid PET has become a pivotal imaging biomarker for Alzheimer disease (AD), enabling in vivo detection and quantification of β-amyloid deposition. However, variability in quantitative measurements ...

Some patients with a common type of stroke benefit from a clot-busting drug given between 4.5 and 24 hours after symptoms emerged, according to a new study.

A study led by a speech neuroscientist at The University of Texas at Dallas sheds light on how damage from stroke disrupts the brain mechanisms required for fluent speech. The research, published in ...

A minister has issued an update on stroke treatment. Stroke patients require immediate treatment to prevent lasting or irreversible harm. Among the most frequently used interventions is a thrombectomy ...

Atrial fibrillation is a common heart condition characterized by a rapid, irregular heartbeat stemming from the heart's upper chamber. It is a leading cause of stroke from clots that form in a small ...

SUMTER COUNTY, Fla. — A new lifesaving service is now serving part of Sumter County. University of Florida Health launched a mobile stroke treatment unit (MSTU) in the Villages on July 23. Every ...

Tom Devlin, MD, PhD, stroke neurologist and medical director of CommonSpirit - Memorial Hospital - Neuroscience Institute, served as the international principal investigator for two pivotal phase two ...

The risk of recurrent ischemic stroke can be reduced by managing modifiable risk factors and instituting a regimen of mechanism-specific secondary stroke prevention. Strategies for secondary ...

A Washington state jury awarded $24 million to the family of a man who died due to stem cell treatment negligence after ...

Background Intracerebral hemorrhage (ICH) is the stroke subtype with the highest mortality and disability rates, and early hematoma evacuation is crucial for improving prognosis. Compared to ...

OCEANIC-STROKE shows asundexian cuts ischemic stroke recurrence by 26% in patients taking standard antiplatelet therapy, with no major bleeding increase. Asundexian is a direct oral inhibitor of FXIa ...